QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events

Yale University

Status: Completed

Conditions: Diabetes; Diabetes Mellitus

Treatments: Other: QBSAfe Toolkit

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04514523

1R21AG061427-01 (U.S. NIH Grant/Contract)

2000026483

19-004560

Details and patient eligibility

About

The purpose of this study is to co-develop a toolkit (known as the QBSAfe toolkit) with patients, family caregivers, and clinicians that focuses on palliating symptoms, alleviating burden of treatment, facilitating social connections, and optimizing treatment safety for patients with diabetes mellitus.

Enrollment: 91 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

-Existing diagnosis of diabetes mellitus; have an existing appointment with a participating clinician

Exclusion criteria

• Do not speak English
• Severe vision/hearing impairment
• Unable to give informed consent for any reason

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

91 participants in 1 patient group

Implementation Arm

Experimental group

Treatment:

Other: QBSAfe Toolkit